Yanguo Su
-
- Curcumin's Biomedical Applications 2
-
- Natural Compounds in Disease Treatment 2
-
- Nanoplatforms for cancer theranostics 6
-
- Immune cells in cancer 3
- Immunotherapy and Immune Responses 2
-
- Neurological Disease Mechanisms and Treatments 2
-
- Inflammasome and immune disorders 2
-
- Sulfur Compounds in Biology 2
- Journals
- Small (1 paper)Carbohydrate Polymers (1 paper)International Journal of Biological Macromolecules (4 papers)
- Partner nations
- China
In The Last Decade
Yanguo Su
18 papers receiving 359 citations
Peers
Comparison fields: 5 of 77
- Biomaterials 82
- Molecular Medicine 31
- Pharmaceutical Science 21
- Complementary and alternative medicine 26
- Pharmacology 26
Countries citing papers authored by Yanguo Su
This map shows the geographic impact of Yanguo Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanguo Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanguo Su more than expected).
Fields of papers citing papers by Yanguo Su
This network shows the impact of papers produced by Yanguo Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanguo Su. The network helps show where Yanguo Su may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yanguo Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 11 | |
| 2 | 2025 | 5 | |
| 3 | 2024 | 8 | |
| 4 | 2023 | 8 | |
| 5 | 2023 | 14 | |
| 6 | 2023 | 14 | |
| 7 | 2022 | 11 | |
| 8 | 2022 | 15 | |
| 9 | 2022 | 15 | |
| 10 | 2022 | 23 | |
| 11 | 2022 | 43 | |
| 12 | 2022 | 54 | |
| 13 | 2022 | 7 | |
| 14 | 2022 | 6 | |
| 15 | 2022 | 19 | |
| 16 | 2022 | 5 | |
| 17 | 2021 | 93 | |
| 18 | 2021 | 12 |
About Yanguo Su
Yanguo Su is a scholar working on Biochemistry, Molecular Medicine and Immunology, having authored 18 papers that have together received 363 indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (6 papers), Immune cells in cancer (3 papers), Neurological Disease Mechanisms and Treatments (2 papers), Curcumin's Biomedical Applications (2 papers), Inflammasome and immune disorders (2 papers), Natural Compounds in Disease Treatment (2 papers), Immunotherapy and Immune Responses (2 papers) and Sulfur Compounds in Biology (2 papers). The work is most often cited by research in Biomaterials (82 citations), Molecular Medicine (31 citations) and Pharmaceutical Science (21 citations). Yanguo Su has collaborated with scholars based in China. Frequent co-authors include Daquan Chen, Chunjing Guo, Huimin Guo, Changgang Sun, Qiang Chen, Zhenfeng Wu, Xue Liu, Jinqiu Wang, Hongjie Mu and Ming Kong. Their work appears in journals such as Small, Carbohydrate Polymers and International Journal of Biological Macromolecules.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.